Abiopharma

Conference call to review the financial statements as of 30.6.26 on 31.8.26 at 10:00

Dividend in the amount of 28.059 agorot per share, record date: 28.8.26, payment 6.9.26

Q2/half-yearly Periodic report for 2026

The company’s liability position as of 30.6.26, by repayment dates

Notice of annual meeting for 24.9.26 – reappointments, compensation policy, indemnification and exemption, update of employment terms and voting letter

Change in corporate details

Update regarding the memorandum of understanding of the subsidiary company for carrying out combined transactions for the sale of an unspecified half of 3 assets of long-term rental housing

Register of shareholders, changes and capital status – exercise of non-tradable warrants

Change in holdings of interested parties/officers

Register of shareholders, changes and capital status – exercise of non-tradable warrants